11/14/2024
3:26 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
CytomX Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
2:03 PM | Cormorant Asset Management, LP (Filed by)
CytomX Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
11:28 AM | CytomX Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
08/22/2024
4:58 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
4:59 PM | CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
5:00 PM | CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
5:01 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/22/2024
5:01 PM | CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
11:15 PM | CytomX Therapeutics (Filer)
| Form EFFECT | |
06/17/2024
3:35 PM | CytomX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
4:36 PM | CytomX Therapeutics (Issuer)
Su Zhen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:36 PM | CytomX Therapeutics (Issuer)
Young Matthew P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:31 PM | Ashworth Alan (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:32 PM | CytomX Therapeutics (Issuer)
Gilbert Halley E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:33 PM | CytomX Therapeutics (Issuer)
Jones Elaine V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:34 PM | CytomX Therapeutics (Issuer)
Meyers James R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:34 PM | CytomX Therapeutics (Issuer)
Mohindru Mani (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
3:00 PM | Cormorant Asset Management, LP (Filed by)
CytomX Therapeutics (Subject)
| Form SC 13G | |
05/08/2024
3:41 PM | CytomX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
5:06 AM | CytomX Therapeutics (Filer)
| Form DEFA14A | |
04/04/2024
3:31 PM | CytomX Therapeutics (Filer)
| Form DEF 14A | |
04/04/2024
3:33 PM | CytomX Therapeutics (Filer)
| Form DEFA14A | |
03/28/2024
6:12 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
4:15 PM | CytomX Therapeutics (Filer)
| Form PRE 14A | |
03/22/2024
3:27 PM | CytomX Therapeutics (Issuer)
Su Zhen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:36 PM | CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:37 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:38 PM | CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:40 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:41 PM | CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:30 PM | CytomX Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/19/2024
7:41 PM | CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:43 PM | CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:44 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:37 PM | Chu Yu-Waye (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:38 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:40 PM | CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
